Metropolis deepens tier-II and III diagnostics network as smaller towns drive growth
Metropolis Healthcare has added 70–75 labs in smaller towns over three years and now serves about 750 towns. Tier-III and beyond contribute 27–28% of business, while June-quarter FY27 revenue rose 17% to ₹450 crore and net profit increased 26% to ₹57 crore.
Metropolis Healthcare is expanding diagnostics labs, collection centres and partnerships across smaller Indian towns as organized testing demand rises. It has also made acquisitions to deepen regional and specialist capabilities, while reporting strong June-quarter FY27 revenue, profit and margin growth.
Why this matters
The expansion supports Metropolis's prior 14–15% FY27 revenue-growth guidance without price hikes and follows Q1 profit growth driven by TruHealth and tier-III markets.
Retail-company signal activity is accelerating, up 125767% QoQ.